A detailed history of Northwestern Mutual Wealth Management CO transactions in Scynexis Inc stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 87 shares of SCYX stock, worth $102. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87
Previous 87 -0.0%
Holding current value
$102
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$1.83 - $2.93 $159 - $254
87 New
87 $0
Q2 2022

Aug 04, 2022

SELL
$1.77 - $3.87 $1,752 - $3,831
-990 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$3.56 - $6.66 $3,524 - $6,593
990 New
990 $4,000

Others Institutions Holding SCYX

About SCYNEXIS INC


  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $38.5M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.